47 hedge funds and large institutions have $12.9M invested in BioVie in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

0.01% more ownership

Funds ownership: 0.04%0.05% (+0.01%)

1% less call options, than puts

Call options by funds: $558K | Put options by funds: $564K

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$558K
Puts
$564K
Net Calls
Net Calls Change

Top Buyers

1 +$2.82M
2 +$1.56M
3 +$1.02M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$889K
5
BFM
Boothbay Fund Management
New York
+$510K

Top Sellers

1 -$2.31M
2 -$742K
3 -$143K
4
6CM
683 Capital Management
New York
-$125K
5
FIA
FNY Investment Advisers
New York
-$110K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.82M
2
$1.56M
3
$1.24M
4
$1.16M
5
$971K
6
$602K
7
$437K
8
$354K
9
$279K
10
$238K
11
$236K
12
$221K
13
$209K
14
$208K
15
$199K
16
$195K
17
$195K
18
$169K
19
$162K
20
$162K
21
$139K
22
$139K
23
$138K
24
$131K
25
$127K